E.D.E.N. Atlantic
Question-first biology

We find undiscovered questions in biology and healthcare.

When a question matters, we build the right vehicle around it: a novel experiment, an expert consortium, or a company spinout.

Human Luminaries and AI scientist lab partners work in real time to map evidence, sharpen the question, and route the next action.

What we do
01

Question-first discovery

We begin before the model, experiment, grant, or company has been assumed. Human Luminaries and AI scientist lab partners work hand in hand to find the unclosed loops: dead ends, broken threads, inherited assumptions, and unresolved mechanisms that reveal the question worth building around.

02

Novel experiments + expert consortia

When a question requires more than one lab, we organize the scientists, clinicians, datasets, institutions, government and defense partners, validation paths, experiments, and publications needed to pursue it.

03

Company spinouts

When a question reveals a new product, platform, or market, we spin out or co-build focused companies to pursue it.

How we move faster

Discovery is always on.

Discover, Map, Rank, and Activate do not happen in sequence. Every new signal can surface a question, update the map, change what matters most, and move the right work forward while human scientists and AI scientist lab partners continue sharpening the system in real time.

01
Discover Human Luminaries and AI scientist lab partners surface undiscovered questions by finding unclosed loops in data, literature, mechanisms, assumptions, and domain expertise.
03
Rank The system continuously updates which questions are most likely to change diagnosis, intervention, validation, partnership, or company-formation decisions.
Always-on research system Living Question Map The order is not the process. The process is concurrent.
02
Map Questions are connected to disease states, evidence gaps, candidate biomarkers, interventions, risks, and validation paths.
04
Activate AI scientist lab partners generate hypotheses, computational experiments, validation briefs, manuscript outlines, and collaboration paths for human review.
The order is not the process. The process is concurrent: discovery, evidence mapping, ranking, validation planning, writing, and collaboration can move at the same time.
Real time

A printout waiting on a scientist’s chair before they arrive.

Real time

A 2:00 AM alert to the researcher who needs to see a finding now.

Real time

A paper outline, experiment brief, and collaborator map already in motion.

Worked case study
Worked case study: AMSA-G
Atlantic Morphogenetic State Atlas — Glioma
Unclosed loop

The Human Genome Project mapped the code. Cell atlases mapped the parts. But medicine still lacks a practical map of the state transitions that occur before disease becomes clinically visible.

Mapping brain-tissue state before glioma is visible.

AMSA-G is E.D.E.N. Atlantic’s first worked case study: an AI-scientist research architecture for glioma. It asks whether glioma begins as a measurable shift in brain-tissue state before it appears as a tumor — and whether that drift can be mapped early enough to change detection, intervention, or drug-development strategy.

Instead of waiting for one step to finish before the next begins, AMSA-G coordinates specialized AI scientists around one atlas so candidate diagnostic signals, therapeutic hypotheses, risk checks, computational experiments, evidence review, manuscript drafts, and collaboration briefs can develop in parallel.

1Atlas AI ScientistsBuild and update disease-state maps across healthy, transitional, and glioma states.
2Diagnostic AI ScientistsSearch for early drift signals before visible disease and generate candidate state scores for human review.
3Therapeutic AI ScientistsRank intervention hypotheses and identify variables that may stabilize or reverse biological drift.
4Second-Order Effect AI ScientistsFlag therapy escape, migration risk, and paths that could accidentally worsen spread.
Shared Disease-State Model Healthy → Drift → Glioma · All AI scientists read from and contribute to the same evolving atlas.
5Literature Validation AI ScientistsScore evidence, contradictions, and hypothesis risk before human review.
6Proposal + Manuscript AI ScientistsTurn reviewed findings into experiment plans, grant drafts, pharma briefs, and manuscript outlines.
7Scientific Producer AI ScientistMatch findings to labs, hospitals, research institutions, government and defense partners, and collaboration pathways.
8In Silico Experiment AI ScientistsDefine, run, and document computational experiments, methods, results, and lab-ready protocols.

What this means

AMSA-G is always on: discovering, mapping, ranking, and activating work around undiscovered questions while generating candidate diagnostics, therapeutic hypotheses, risk checks, computational experiments, manuscript drafts, and collaborator briefs in parallel.

Case study: data marketplace

Certified data and validated lab capacity.

This case study explores a consortium across universities, hospitals, startup cloud labs, community and open lab space, and expert scientists: a trusted marketplace where healthcare data can be certified, validated, and made useful for AI-ready research.

Undiscovered question

What unclosed loop keeps valuable health data from becoming trusted, AI-ready research infrastructure?

The data exists. The demand exists. The experts and labs exist. The missing layer is trust, certification, access terms, and validation capacity organized as one working system.
01 Certified data

Curate, normalize, provenance-check, and certify datasets so human researchers and AI scientist lab partners can work from data they can trust.

02 Validation layer

Track how questions, protocols, computational results, and wet-lab findings move through review so partners can see what has been tested and by whom.

03 Lab activation network

Match validated questions to qualified scientists, community labs, hospital collaborators, and open lab space for fast follow-on work.

Scientific posture

Human scientists approve all claims, communications, and translation.

E.D.E.N. Atlantic is built for discovery, research prioritization, collaboration, and translational infrastructure. Outputs are not autonomous clinical decisions, diagnoses, or patient-facing instructions.

Selected case studies and active spinouts are available under NDA.

Before biology becomes a diagnosis, it may become a pattern.

Start a research conversation.

E.D.E.N. Atlantic works with government and defense partners, research institutions, scientists, labs, hospitals, and collaborators pursuing hard questions in biology and healthcare.

Get in touch

Government and defense partnerships: amanda@spacevibes.org · 310-494-1665

Consortium and pharma partnerships: alex@spacevibes.org

Start-up, wet-lab, organizational, and other partnerships: ava@spacevibes.org